Education
About Us
Working with TipRanks
Follow Us
Aaron Ondrey Insider Profile
4 Followers
Aaron Ondrey, CFO at Mirati Therapeutics, holds 128.17K shares in Rocket Pharmaceuticals (Ticker: RCKT), holds 0.00 shares in Mirati Therapeutics (Ticker: MRTX). Most recently, Aaron Ondrey Sold ― shares of Rocket Pharmaceuticals on Jul 08, 2025 for an estimated value of $4.25K.
Profitable Transactions
1 out of 2 Profitable Transactions
Average Return
+16.60%
Average return per transaction
Time Frame
Compare to
Insider Roles
CFO
Roles that Aaron Ondrey holds in companies
Most Profitable Insider Trade
The most profitable trade made by Aaron Ondrey
Aaron Ondrey's Trading History
Mirati Therapeutics
Jan 23, 2024
―
Uninformative Sell
―
$0.00
Rocket Pharmaceuticals
Jul 08, 2025
CFO
Informative Sell
4.25K
$388.36K
List of latest transactions for each holding click on a transaction to see Aaron Ondrey's performance on stock
You May Also Like
Aaron Ondrey insider profile FAQ
What is the percentage of profitable transactions made by Aaron Ondrey?
The percentage of profitable transactions made by Aaron Ondrey is 50%.
What is the average return per transaction made by Aaron Ondrey?
The average return per transaction made by Aaron Ondrey is 16.60%.
What stocks does Aaron Ondrey hold?
Aaron Ondrey holds: MRTX, RCKT stocks.
What was Aaron Ondrey’s latest transaction?
Aaron Ondrey latest transaction was an Informative Sell of $4.25K.
What was Aaron Ondrey's most profitable transaction?
Aaron Ondrey’s most profitable transaction was an Informative Sell of RCKT stock on April 8, 2025. The return on the trade was 36.30%.
What is Aaron Ondrey's role in Mirati Therapeutics?
Aaron Ondrey's role in Mirati Therapeutics is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.